Literature DB >> 10808168

Increased nitric oxide production in the respiratory tract in asymptomatic pacific islanders: an association with skin prick reactivity to house dust mite.

A Moody1, W Fergusson, A Wells, J Bartley, J Kolbe.   

Abstract

BACKGROUND: Exhaled nitric oxide (NO) is increased in asthma and may also be increased in subclinical airway inflammation. The relationship between atopy and subclinical airway inflammation in the pathogenesis of asthma remains unclear. We have evaluated the relationship between exhaled NO levels and skin prick test reactivity to 8 common allergens in 64 asymptomatic adult Pacific Islanders. Pacific Islanders were studied as a racial group with major morbidity from asthma.
OBJECTIVE: Our purpose was to determine whether asymptomatic subjects with skin prick test reactivity to common allergens have elevated NO levels.
METHODS: All subjects underwent full lung function testing and skin prick testing. Exhaled and nasal NO levels were measured by chemiluminescence (Logan LR2000 analyzer) with use of the single-breath and breath-holding techniques, respectively.
RESULTS: House dust mite (HDM) reactivity was seen in 38 of 64 (56%). Exhaled NO levels (median 8.9 ppb, range 2.9-47.3 ppb) and nasal NO levels (527.5 +/- 181.5 ppb) lay above the normal European range in 30% and 25% of subjects, respectively. HDM reactivity was associated with higher exhaled NO levels (P <. 0005) and higher nasal NO levels (P =.01). In HDM-sensitive subjects the wheal size for HDM correlated with exhaled NO levels (r = 0.35, P =.04) and nasal NO levels (r = 0.40, P =.01). On multivariate analysis, exhaled NO levels were independently and positively related to the severity of HDM reactivity (P =.01) and nasal NO levels (P <.02), equation R(2) = 0.27.
CONCLUSION: NO levels are elevated in a significant proportion of asymptomatic Pacific Islanders and are associated with HDM sensitivity. This may denote subclinical airway inflammation in this population and suggests that exposure to HDM in atopic individuals might play an important role in the early pathogenesis of asthma.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10808168     DOI: 10.1067/mai.2000.105318

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  10 in total

1.  Exhaled nitric oxide levels in atopic children: relation to specific allergic sensitisation, AHR, and respiratory symptoms.

Authors:  J D Leuppi; S H Downs; S R Downie; G B Marks; C M Salome
Journal:  Thorax       Date:  2002-06       Impact factor: 9.139

2.  Exhaled NO level and number of eosinophils in nasal lavage as markers of pollen-induced upper and lower airway inflammation in children sensitive to grass pollen.

Authors:  J G C van Amsterdam; E W M A Bischoff; A de Klerk; A P J Verlaan; L M N Jongbloets; H van Loveren; A Opperhuizen; G Zomer; M Hady; F T M Spieksma; J A M A Dormans; P A Steerenberg
Journal:  Int Arch Occup Environ Health       Date:  2003-02-26       Impact factor: 3.015

3.  Increase in exhaled nitric oxide (eNO) after work-related isocyanate exposure.

Authors:  L Barbinova; X Baur
Journal:  Int Arch Occup Environ Health       Date:  2006-01-19       Impact factor: 3.015

Review 4.  Exhaled nitric oxide measurements: clinical application and interpretation.

Authors:  D R Taylor; M W Pijnenburg; A D Smith; J C De Jongste
Journal:  Thorax       Date:  2006-09       Impact factor: 9.139

5.  Exhaled nitric oxide in sarcoidosis.

Authors:  M L Wilsher; W Fergusson; D Milne; A U Wells
Journal:  Thorax       Date:  2005-10-21       Impact factor: 9.139

6.  Clinical patterns in asthma based on proximal and distal airway nitric oxide categories.

Authors:  James L Puckett; Richard W E Taylor; Szu-Yun Leu; Olga L Guijon; Anna S Aledia; Stanley P Galant; Steven C George
Journal:  Respir Res       Date:  2010-04-28

Review 7.  The clinical significance of exhaled nitric oxide in asthma.

Authors:  Sachin Pendharkar; Sanjay Mehta
Journal:  Can Respir J       Date:  2008-03       Impact factor: 2.409

8.  Assessment of airway inflammation with exhaled NO measurement.

Authors:  E Hatziagorou; J Tsanakas
Journal:  Hippokratia       Date:  2007-04       Impact factor: 0.471

Review 9.  Exhaled nitric oxide in the clinical management of asthma.

Authors:  Chitra Dinakar
Journal:  Curr Allergy Asthma Rep       Date:  2004-11       Impact factor: 4.919

10.  Contributions of asthma, rhinitis and IgE to exhaled nitric oxide in adolescents.

Authors:  Bess M Flashner; Sheryl L Rifas-Shiman; Emily Oken; Carlos A Camargo; Thomas A E Platts-Mills; Lisa Workman; Augusto A Litonjua; Diane R Gold; Mary B Rice
Journal:  ERJ Open Res       Date:  2021-04-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.